Literature DB >> 16784069

Body mass index: a risk factor for 30-day or six-month mortality in patients undergoing aortic valve replacement?

Ines Florath1, Alexander A Albert, Ulrich P Rosendahl, Wael M Hassanein, Stefan Bauer, Ina C Ennker, Juergen C Ennker.   

Abstract

BACKGROUND AND AIM OF THE STUDY: In recent studies, the impact of a low or high body mass index (BMI) on outcome after cardiac surgery has been the subject of controversy. A retrospective study was conducted to determine the influence of BMI on 30-day and six-month mortality after aortic valve replacement (AVR).
METHODS: A multivariable logistic regression was performed on data from 1,241 consecutive patients (mean age 69 +/- 11 years) who underwent AVR either with (n = 514; 41%) or without coronary artery bypass grafting CABG between 2000 and 2003. A wide spectrum of periprocedural variables was collected, including laboratory data as markers for nutritional status and comorbidity. Patients were followed up for six months after AVR (99% complete).
RESULTS: Mortality rates after 30 days and after six months were 3.9% (n = 49) and 7.6% (n = 94), respectively. A low BMI was identified as an independent risk factor for 30-day (OR (odds ratio) 0.87; CI (confidence interval) 0.8-0.94) and six-month mortality (OR 0.91; CI 0.86-0.96). The relationship between the logit function and BMI was linear; however, a BMI value of 24 was considered an appropriate cut-off point. Both models containing the BMI linearly or dichotomic were equivalent. As patients with a lower BMI differ in their preoperative risk profile compared to those with a higher BMI, a saturated propensity score estimating the propensity towards having a BMI < 24 was calculated. The propensity score was not significant in the final models for 30-day and six-month mortality (0.24 and 0.73, respectively), and the OR for BMI remained largely unaltered (0.89 and 0.91, respectively).
CONCLUSION: A BMI < 24 is predictive of an increased risk of mortality after AVR, independently of malnutrition, advanced heart disease, or valve size. Further studies are required to investigate the role of adipose tissue in extreme situations and chronic disease. It is mandatory to include BMI in outcome studies after AVR.

Entities:  

Mesh:

Year:  2006        PMID: 16784069

Source DB:  PubMed          Journal:  J Heart Valve Dis        ISSN: 0966-8519


  4 in total

1.  Predicting 30-day mortality of aortic valve replacement by the AVR score.

Authors:  B M Swinkels; F E E Vermeulen; J C Kelder; W J van Boven; H W M Plokker; J M Ten Berg
Journal:  Neth Heart J       Date:  2011-06       Impact factor: 2.380

Review 2.  Critical appraisal of the obesity paradox in cardiovascular disease: how to manage patients with overweight in heart failure?

Authors:  Wolfram Doehner
Journal:  Heart Fail Rev       Date:  2014-09       Impact factor: 4.214

3.  Short-term and long-term outcome in low body mass index patients undergoing cardiac surgery.

Authors:  Nael Al-Sarraf; Adnan Raza; Suzanne Rowley; Anne Hughes; Michael Tolan; Vincent Young; Eillish McGovern
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-02-12

4.  The impact of nutritional status and appetite on the hospital length of stay and postoperative complications in elderly patients with severe aortic stenosis before aortic valve replacement.

Authors:  Dariusz Jagielak; Edyta Wernio; Radosław Kozaryn; Peter Bramlage; Marta Gruchała-Niedoszytko; Jan Rogowski; Sylwia Małgorzewicz
Journal:  Kardiochir Torakochirurgia Pol       Date:  2016-06-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.